Clinical trial · Observational

Application of DWI in Diagnosis of Prostate Cancer

Different Models of Multiple B-value DWI and Their Applications in Diagnosis of Prostate Cancer

NCT04962269CI-TRIAL-00052684completedClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

This study compared the performance of different models of multiple b-value DWI in diagnosing prostate cancer.

Conditions

Conditions (2)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Benign Prostatic Hyperplasia	Benign Prostatic Hyperplasia	ONTOLOGY_EXACT	0.98
Prostate Cancer	Malignant Prostate Neoplasm	CURATED_EXACT	0.92

Interventions

Interventions (1)

Intervention	Type	Mapped drug	Match
MRI	Diagnostic Test	—	UNRESOLVED

Design

Arms and outcomes

Arms (2)

label
prostate cancer
description
The patient was pathologically diagnosed with prostate cancer
interventionNames
1. Diagnostic Test: MRI
label
benign prostatic hyperplasia
description
The patient was pathologically diagnosed with benign prostatic hyperplasia

Primary outcomes (1)

measure
pathological diagnosis
timeFrame
2013.10-2018.6
description
prostate cancer or benign prostatic hyperplasia

Eligibility

Eligibility (as posted)

Sex: Male

Show eligibility criteria text

Inclusion Criteria:

1. The exam including T1WI、T2WI and multiple b-value DWI.
2. Comfired by pathology as prostate cancer or benign prostatic hyperplasia in one month after the MRI exam.

Exclusion Criteria:

* 1.No Gleason score data. 2.Awful quality of imagings or artifacts affectting diagnosis. 3.No lesion larger than 0.5cm. 4.Any surgery or treatment before MRI exam. 5.Biopsy in 4 weeks before MRI exam.

References

Publications (0)

Data not yet available

No reference posted for this study.